Oral active matrix metalloproteinase-8 immunotest may be less accurate in haemato-oncologic patients.
Sign Up to like & getrecommendations! Published in 2022 at "Oral diseases"
DOI: 10.1111/odi.14335
Abstract: OBJECTIVES This study examines associations of active matrix metalloproteinase-8 (aMMP-8) point-of-care immunotest (Periosafe) outcomes with oral health of patients with haemato-oncologic diseases. METHODS Adult patients diagnosed with haematological diseases aimed to be treated with haematopoietic… read more here.
Keywords: oncologic patients; immunotest; active matrix; ammp immunotest ... See more keywords